Banks

Pharmaron Beijing Co, a Chinese pharmaceutical research and development service platform, started testing investor appetite for its IPO on Monday.

BMW Auto Finance (China) is planning a return to the auto loan ABS market next week with a Rmb8bn ($1.1bn) deal.

Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.

The $166.3m loan to support Blackstone Group’s Essel Propack acquisition has been oversubscribed, with 10 participants joining during general syndication.

Cellnex, the Spanish telecommunications company, has closed the books on its cash call to fund its acquisition of Arqiva's tower business, attracting huge levels of demand for shares.

Cerberus Capital Management has sold more than half of its stake in Bawag, the Austrian banking group, via an accelerated bookbuild.

Adira Dinamika Multi Finance, an Indonesian motor vehicle financier, is making a quick return to loans, seeking its second offshore borrowing this year.

Hutchison Port Holdings Trust seized the market window immediately after the Federal Open Market Committee meeting to sell a $500m five year bond on Thursday.

Central China Real Estate priced a $200m four non-call two year bond on Thursday, after surprisingly strong demand allowed it to tighten pricing aggressively.

Goldman Sachs’ co-head of China investment banking Hansong Zhu is retiring after 19 years with the bank, according to an internal memo seen by GlobalCapital Asia.

Chinese pharmaceuticals firm WuXi Biologics and one of its controlling shareholders are set to raise a combined HK$7.9bn ($1bn) from the sale of equal chunks of shares in the company.

South Korean defence and information technology firm Hanwha Systems priced its IPO at the bottom of the range on Friday after a poor showing from investors at home and abroad, according to a source close to the deal.